DE3686684D1 - Mittel zur absorptionsverbesserung von proteinen. - Google Patents

Mittel zur absorptionsverbesserung von proteinen.

Info

Publication number
DE3686684D1
DE3686684D1 DE8686902132T DE3686684T DE3686684D1 DE 3686684 D1 DE3686684 D1 DE 3686684D1 DE 8686902132 T DE8686902132 T DE 8686902132T DE 3686684 T DE3686684 T DE 3686684T DE 3686684 D1 DE3686684 D1 DE 3686684D1
Authority
DE
Germany
Prior art keywords
agent
improving protein
protein absorption
absorption
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686902132T
Other languages
English (en)
Other versions
DE3686684T2 (de
Inventor
Jay Sarnoff
E Sobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meridian Medical Technologies Inc
Original Assignee
Survival Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,845 external-priority patent/US4661469A/en
Priority claimed from US06/782,441 external-priority patent/US4772585A/en
Application filed by Survival Technology Inc filed Critical Survival Technology Inc
Application granted granted Critical
Publication of DE3686684D1 publication Critical patent/DE3686684D1/de
Publication of DE3686684T2 publication Critical patent/DE3686684T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8686902132T 1985-03-06 1986-03-06 Mittel zur absorptionsverbesserung von proteinen. Expired - Fee Related DE3686684T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/708,845 US4661469A (en) 1984-08-08 1985-03-06 t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A 1985-03-27 1985-03-27
US06/782,441 US4772585A (en) 1984-08-08 1985-10-01 Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en) 1985-03-06 1986-03-06 Protein absorption enhancing agents

Publications (2)

Publication Number Publication Date
DE3686684D1 true DE3686684D1 (de) 1992-10-15
DE3686684T2 DE3686684T2 (de) 1993-01-28

Family

ID=27418848

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686902132T Expired - Fee Related DE3686684T2 (de) 1985-03-06 1986-03-06 Mittel zur absorptionsverbesserung von proteinen.

Country Status (9)

Country Link
EP (1) EP0214281B1 (de)
AT (1) ATE80306T1 (de)
AU (1) AU593794B2 (de)
DE (1) DE3686684T2 (de)
DK (1) DK528386A (de)
FI (1) FI864480A0 (de)
HU (1) HUT41632A (de)
NO (1) NO864382D0 (de)
WO (1) WO1986005096A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839170A (en) * 1985-10-01 1989-06-13 Survival Technology, Inc. Protein absorption enhancing agents
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3682104D1 (de) * 1985-04-22 1991-11-28 Genentech Inc Plasminogenaktivator-mutante des menschlichen gewebes, verfahren und zwischenprodukte dafuer und diese mutante verwendende zusammensetzungen.
NZ216306A (en) * 1985-05-28 1989-10-27 Wellcome Found Pharmaceutical compositions containing tissue plasminogen activator

Also Published As

Publication number Publication date
EP0214281A1 (de) 1987-03-18
DE3686684T2 (de) 1993-01-28
FI864480A (fi) 1986-11-04
DK528386D0 (da) 1986-11-05
NO864382L (no) 1986-03-11
DK528386A (da) 1986-11-05
AU5581186A (en) 1986-09-24
EP0214281B1 (de) 1992-09-09
HUT41632A (en) 1987-05-28
NO864382D0 (no) 1986-11-03
FI864480A0 (fi) 1986-11-04
AU593794B2 (en) 1990-02-22
ATE80306T1 (de) 1992-09-15
WO1986005096A1 (en) 1986-09-12
EP0214281A4 (de) 1989-03-16

Similar Documents

Publication Publication Date Title
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3685625D1 (de) Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
DE3687741D1 (de) Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
DK317288A (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DE3676601D1 (de) Mittel zur injektion von aktiviertem vitamin-d3.
IT1067019B (it) Metodo e disposizione per misurare la concentrazione di composti di basso peso molecolare in mezzi complessi in particolare nel trattamento medicale
NO881904L (no) Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
DE3686684D1 (de) Mittel zur absorptionsverbesserung von proteinen.
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
IL76121A0 (en) Protein absorption enhancing agents
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
ATE79550T1 (de) Die proteinabsorption verbessernde stoffe.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
NO864742D0 (no) Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
ATE88359T1 (de) Aspirator zur aufnahme von koerperfluessigkeiten.
DK381787A (da) Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
IT8621271A0 (it) Metodo per deteminare la presenza di igg specifica in sieri umani.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee